You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 260 No. 11, September 16, 1988 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Brief Reports
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Acyclovir Prevents Reactivation of Herpes Simplex Labialis in Skiers

Spotswood L. Spruance, MD; Mary Lou Hamill, PharmD; William S. Hoge, RPh; L. Gray Davis, MS; John Mills, MD

JAMA. 1988;260(11):1597-1599.


Abstract

To determine the effectiveness of an antiviral to prevent herpes labialis during a brief, high-risk circumstance, 147 persons with a history of sun-induced recurrences were treated prophylactically with oral acyclovir or matching placebo and were observed during their ski holidays. Five (7%) of 75 acyclovir-treated subjects developed lesions compared with 19 (26%) of 72 persons in the placebo group.

(JAMA 1988;260:1597-1599)



Author Affiliations

From the Department of Medicine, University of Utah School of Medicine (Dr Spruance), and the Department of Pharmacy Practice, College of Pharmacy (Dr Hamill and Mr Hoge), University of Utah, Salt Lake City; the Departments of Medicine and Microbiology, University of California, San Francisco (Dr Mills); and the Virology Section, Burroughs Wellcome Co, Research Triangle Park, NC (Ms Davis).


Footnotes

Reprint requests to Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132 (Dr Spruance).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment and prevention of herpes labialis
Opstelten et al.
cfp 2008;54:1683-1687.
ABSTRACT | FULL TEXT  

The Treatment of Herpes Simplex Infections: An Evidence-Based Review
Cernik et al.
Arch Intern Med 2008;168:1137-1144.
ABSTRACT | FULL TEXT  

The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures
MILLER et al.
Journal of the American Dental Association 2004;135:1311-1318.
ABSTRACT | FULL TEXT  

Oral Antivirals for the Acute Treatment of Recurrent Herpes Labialis
Jensen et al.
The Annals of Pharmacotherapy 2004;38:705-709.
ABSTRACT | FULL TEXT  

Can We Prevent Recurrences of Herpes Infections without Antiviral Drugs? The Weisenfeld Lecture
Kaufman
IOVS 2002;43:1325-1329.
FULL TEXT  

A Review of Antiviral Therapy for Herpes Labialis
Vander Straten et al.
Arch Dermatol 2001;137:1232-1235.
FULL TEXT  

Antiviral Drugs
Balfour
NEJM 1999;340:1255-1268.
FULL TEXT  

Acyclovir for the Prevention of Recurrent Herpes Simplex Virus Eye Disease
Wilhelmus et al.
NEJM 1998;339:300-306.
ABSTRACT | FULL TEXT  

Molecular Aspects of Herpes Simplex Virus I Latency, Reactivation, and Recurrence
Miller et al.
CROBM 1998;9:541-562.
ABSTRACT | FULL TEXT  

ACYCLOVIR PREVENTS HERPES LABIALIS REACTIVATION IN SKIERS
JWatch General 1988;1988:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.